✨ Your Portfolio is fetched and updated from zerodha.
Nano Services
Market Cap
₹20 Cr.
P/E
0.00
  • Vanta Bioscience
  • Shangar Decor
  • MIG Media Neurons

FAQs on Vanta Bioscience Ltd. Shareprice

Vanta Bioscience has given lower returns compared to its competitors.
Vanta Bioscience has grown at ~-27.68% over the last 3yrs while peers have grown at a median rate of 0.0%

Vanta Bioscience is not expensive.
Latest PE of Vanta Bioscience is 0.0, while 3 year average PE is 164.
Also latest EV/EBITDA of Vanta Bioscience is 0.0 while 3yr average is 33.1.

Growth Table

  • Vanta Bioscience Ltd.
  • Shangar Decor
  • MIG Media Neurons

Balance Sheet

  • Vanta Bioscience Ltd.
  • Shangar Decor
  • MIG Media Neurons

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Vanta Bioscience Ltd.
  • Shangar Decor
  • MIG Media Neurons

Cash Flow

  • Vanta Bioscience Ltd.
  • Shangar Decor
  • MIG Media Neurons

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Vanta Bioscience Ltd.
  • Shangar Decor
  • MIG Media Neurons

Quarterly Results

  • Vanta Bioscience Ltd.
  • Shangar Decor
  • MIG Media Neurons

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*

FAQs on Vanta Bioscience Ltd. Financials

Vanta Bioscience balance sheet is weak and might have solvency issues

Yes, The net debt of Vanta Bioscience is increasing.
Latest net debt of Vanta Bioscience is ₹69.86 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹60.95 Crs.

The profit is oscillating.
The profit of Vanta Bioscience is -₹13.29 Crs for TTM, -₹2.32 Crs for Mar 2024 and -₹6.48 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Vanta Bioscience latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Capital Work in Progress, Inventory, Accounts Receivable, Short Term Loans & Advances

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech